3 antibody; and anti glypican 3 antibody that has a plasma half life that has been modulated by amino acid residue modification, a pharmaceutical composition comprising as an active ingredient the anti glypican 3 antibody, and a method of preparing the anti glypican 3 antibody and producing {HEAD ~ a pharmaceutical composition} comprising {TAIL ~ the anti glypican 3 antibody} as an active ingredient 
comprising
3 antibody ; and anti glypican 3 antibody that has a plasma half life that has been modulated by amino acid residue modification , a pharmaceutical composition comprising as an active ingredient the anti glypican 3 antibody , and a method of preparing the anti glypican 3 antibody and producing { HEAD ~ a pharmaceutical composition } comprising { TAIL ~ the anti glypican 3 antibody } as an active ingredient
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH